IL17A and rheumatoid arthritis: The activation of IL-23/IL-22/IL-17 axis has been recently recognized as a key moment in the acquisition of the inflammatory activity of autoantibodies: in preclinical RA, this axis modulates the glycosylation pattern [102] (see Secretory Immunoglobulins and Aberrant Glycosylation).